The Molecular Machinery of Myelin Gene Transcription in Schwann Cells

Overview

Journal Glia

Specialty Neurology

Date 2008 Sep 23

PMID 18803322

Citations 130

Authors

John Svaren

Dies Meijer

Affiliations

Soon will be listed here.

Abstract

During late fetal life, Schwann cells in the peripheral nerves singled out by the larger axons will transit through a promyelinating stage before exiting the cell cycle and initiating myelin formation. A network of extra- and intracellular signaling pathways, regulating a transcriptional program of cell differentiation, governs this progression of cellular changes, culminating in a highly differentiated cell. In this review, we focus on the roles of a number of transcription factors not only in myelination, during normal development, but also in demyelination, following nerve trauma. These factors include specification factors involved in early development of Schwann cells from neural crest (Sox10) as well as factors specifically required for transitions into the promyelinating and myelinating stages (Oct6/Scip and Krox20/Egr2). From this description, we can glean the first, still very incomplete, contours of a gene regulatory network that governs myelination and demyelination during development and regeneration.

Citing Articles

Yin Yang 1: Function, Mechanisms, and Glia.

Rodriguez-Campuzano A, Castelan F, Hernandez-Kelly L, Felder-Schmittbuhl M, Ortega A Neurochem Res. 2025; 50(2):96.

PMID: 39904836 PMC: 11794380. DOI: 10.1007/s11064-025-04345-7.

Overexpression of Egr1 Transcription Regulator Contributes to Schwann Cell Differentiation Defects in Neural Crest-Specific Knockout Mice.

Zerad L, Gacem N, Gayda F, Day L, Sinigaglia K, Richard L Cells. 2024; 13(23).

PMID: 39682701 PMC: 11639873. DOI: 10.3390/cells13231952.

Role of the Promoter Antisense RNA in Modulating the Schwann Cell Chromatin Landscape.

Martinez Moreno M, Karambizi D, Hwang H, Fregoso K, Michles M, Fajardo E Biomedicines. 2024; 12(11).

PMID: 39595160 PMC: 11592338. DOI: 10.3390/biomedicines12112594.

EGR3 Inhibits Tumor Progression by Inducing Schwann Cell-Like Differentiation.

Chen C, Chen Y, Li Y, Zhang H, Huang X, Li Y Adv Sci (Weinh). 2024; 11(34):e2400066.

PMID: 38973154 PMC: 11425834. DOI: 10.1002/advs.202400066.

Neural regeneration in the human central nervous system-from understanding the underlying mechanisms to developing treatments. Where do we stand today?.

Kvistad C, Krakenes T, Gavasso S, Bo L Front Neurol. 2024; 15:1398089.

PMID: 38803647 PMC: 11129638. DOI: 10.3389/fneur.2024.1398089.

References

Scherer S, Wang D, Kuhn R, Lemke G, Wrabetz L, Kamholz J . Axons regulate Schwann cell expression of the POU transcription factor SCIP. J Neurosci. 1994; 14(4):1930-42. PMC: 6577133. View

Musso M, Balestra P, Bellone E, Cassandrini D, Di Maria E, Doria L . The D355V mutation decreases EGR2 binding to an element within the Cx32 promoter. Neurobiol Dis. 2001; 8(4):700-6. DOI: 10.1006/nbdi.2001.0397. View

Farhadi H, Lepage P, Forghani R, Friedman H, Orfali W, Jasmin L . A combinatorial network of evolutionarily conserved myelin basic protein regulatory sequences confers distinct glial-specific phenotypes. J Neurosci. 2003; 23(32):10214-23. PMC: 6741010. View

Peirano R, Wegner M . The glial transcription factor Sox10 binds to DNA both as monomer and dimer with different functional consequences. Nucleic Acids Res. 2000; 28(16):3047-55. PMC: 108444. DOI: 10.1093/nar/28.16.3047. View

Finzsch M, Stolt C, Lommes P, Wegner M . Sox9 and Sox10 influence survival and migration of oligodendrocyte precursors in the spinal cord by regulating PDGF receptor alpha expression. Development. 2008; 135(4):637-46. DOI: 10.1242/dev.010454. View

Leimeroth R, Lobsiger C, Lussi A, Taylor V, Suter U, Sommer L . Membrane-bound neuregulin1 type III actively promotes Schwann cell differentiation of multipotent Progenitor cells. Dev Biol. 2002; 246(2):245-58. DOI: 10.1006/dbio.2002.0670. View

Darbas A, Jaegle M, Walbeehm E, van den Burg H, Driegen S, Broos L . Cell autonomy of the mouse claw paw mutation. Dev Biol. 2004; 272(2):470-82. DOI: 10.1016/j.ydbio.2004.05.017. View

Friedrich R, Schlierf B, Tamm E, Bosl M, Wegner M . The class III POU domain protein Brn-1 can fully replace the related Oct-6 during schwann cell development and myelination. Mol Cell Biol. 2005; 25(5):1821-9. PMC: 549364. DOI: 10.1128/MCB.25.5.1821-1829.2005. View

Jones E, Jang S, Mager G, Chang L, Srinivasan R, Gokey N . Interactions of Sox10 and Egr2 in myelin gene regulation. Neuron Glia Biol. 2008; 3(4):377-87. PMC: 2605513. DOI: 10.1017/S1740925X08000173. View

10.

Topilko P, Levi G, Merlo G, Mantero S, Desmarquet C, Mancardi G . Differential regulation of the zinc finger genes Krox-20 and Krox-24 (Egr-1) suggests antagonistic roles in Schwann cells. J Neurosci Res. 1998; 50(5):702-12. DOI: 10.1002/(SICI)1097-4547(19971201)50:5<702::AID-JNR7>3.0.CO;2-L. View

11.

Nagarajan R, Svaren J, Le N, Araki T, Watson M, Milbrandt J . EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron. 2001; 30(2):355-68. DOI: 10.1016/s0896-6273(01)00282-3. View

12.

Forghani R, Garofalo L, Foran D, Farhadi H, Lepage P, Hudson T . A distal upstream enhancer from the myelin basic protein gene regulates expression in myelin-forming schwann cells. J Neurosci. 2001; 21(11):3780-7. PMC: 6762685. View

13.

Taveggia C, Pizzagalli A, Fagiani E, Messing A, Feltri M, Wrabetz L . Characterization of a Schwann cell enhancer in the myelin basic protein gene. J Neurochem. 2004; 91(4):813-24. DOI: 10.1111/j.1471-4159.2004.02745.x. View

14.

Wrabetz L, DAntonio M, Pennuto M, Dati G, Tinelli E, Fratta P . Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice. J Neurosci. 2006; 26(8):2358-68. PMC: 6674823. DOI: 10.1523/JNEUROSCI.3819-05.2006. View

15.

Baranek C, Sock E, Wegner M . The POU protein Oct-6 is a nucleocytoplasmic shuttling protein. Nucleic Acids Res. 2005; 33(19):6277-86. PMC: 1275591. DOI: 10.1093/nar/gki947. View

16.

Cosgaya J, Chan J, Shooter E . The neurotrophin receptor p75NTR as a positive modulator of myelination. Science. 2002; 298(5596):1245-8. DOI: 10.1126/science.1076595. View

17.

Zorick T, Syroid D, Brown A, Gridley T, Lemke G . Krox-20 controls SCIP expression, cell cycle exit and susceptibility to apoptosis in developing myelinating Schwann cells. Development. 1999; 126(7):1397-406. DOI: 10.1242/dev.126.7.1397. View

18.

Feltri M, DAntonio M, Quattrini A, Numerato R, Arona M, Previtali S . A novel P0 glycoprotein transgene activates expression of lacZ in myelin-forming Schwann cells. Eur J Neurosci. 1999; 11(5):1577-86. DOI: 10.1046/j.1460-9568.1999.00568.x. View

19.

Le N, Nagarajan R, Wang J, Svaren J, LaPash C, Araki T . Nab proteins are essential for peripheral nervous system myelination. Nat Neurosci. 2005; 8(7):932-40. DOI: 10.1038/nn1490. View

20.

Mager G, Ward R, Srinivasan R, Jang S, Wrabetz L, Svaren J . Active gene repression by the Egr2.NAB complex during peripheral nerve myelination. J Biol Chem. 2008; 283(26):18187-97. PMC: 2440619. DOI: 10.1074/jbc.M803330200. View